The iPhone maker warned that supply constraints and slowing growth would weigh on results in the current quarter.
CareDx, Inc. (CDNA) Q2 2026 Earnings Call Transcript

CareDx has a transplant-testing franchise that taps into recurring surveillance demand and has deeper integration into transplant centers. I also think CDNA's AlloHeme gives them longer-term optionali